| scholarly article | Q13442814 |
| P2093 | author name string | Bo Wang | |
| Jun Liao | |||
| Dan T Simionescu | |||
| Joseph Chen | |||
| Michael Jaeggli | |||
| P2860 | cites work | Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association | Q22306345 |
| Matrix elasticity directs stem cell lineage specification | Q27860761 | ||
| Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves | Q28370005 | ||
| Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord | Q30160386 | ||
| The heterogeneous biomechanics and mechanobiology of the mitral valve: implications for tissue engineering | Q30413608 | ||
| On the biomechanics of heart valve function | Q30479888 | ||
| Heart valve function: a biomechanical perspective | Q30493617 | ||
| Design and Testing of a Pulsatile Conditioning System for Dynamic Endothelialization of Polyphenol-Stabilized Tissue Engineered Heart Valves | Q30498195 | ||
| Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. | Q31083981 | ||
| The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. | Q33226522 | ||
| Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. | Q33239575 | ||
| Mechanobiology of cardiomyocyte development | Q33509740 | ||
| Fibrin sealant in preclinical and clinical studies | Q33765247 | ||
| Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix | Q33802398 | ||
| Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. | Q33902142 | ||
| Human endothelial cell interaction with biomimetic surfactant polymers containing Peptide ligands from the heparin binding domain of fibronectin | Q34049420 | ||
| Cell-seeding techniques in vascular tissue engineering | Q34160631 | ||
| Tensegrity: the architectural basis of cellular mechanotransduction | Q34419882 | ||
| In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model | Q34968778 | ||
| The cardiac valve interstitial cell | Q35024662 | ||
| Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms | Q35083543 | ||
| Mechanical stimuli differentially control stem cell behavior: morphology, proliferation, and differentiation. | Q35529123 | ||
| Endothelial cell seeding of polymeric vascular grafts | Q35672748 | ||
| Review article: Tissue engineering of semilunar heart valves: current status and future developments | Q35746557 | ||
| Application of tissue-engineering principles toward the development of a semilunar heart valve substitute | Q36026430 | ||
| Functional tissue engineering of the aortic heart valve. | Q36281854 | ||
| Electrospinning of polymeric nanofibers for tissue engineering applications: a review | Q36505561 | ||
| Mechanobiological conditioning of stem cells for cartilage tissue engineering. | Q36528390 | ||
| Heart valve tissue engineering: concepts, approaches, progress, and challenges | Q36629931 | ||
| Approaches to heart valve tissue engineering scaffold design | Q36743754 | ||
| Interaction of cells and nanofiber scaffolds in tissue engineering | Q36810131 | ||
| The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology | Q36933045 | ||
| Insights into degenerative aortic valve disease | Q36949031 | ||
| Mechanobiology of the aortic heart valve | Q37118688 | ||
| Engineering controllable anisotropy in electrospun biodegradable nanofibrous scaffolds for musculoskeletal tissue engineering | Q37130496 | ||
| Altered structural and mechanical properties in decellularized rabbit carotid arteries | Q37187418 | ||
| Bioengineering challenges for heart valve tissue engineering | Q37469041 | ||
| Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts | Q37471362 | ||
| Stabilized collagen scaffolds for heart valve tissue engineering | Q37471571 | ||
| Tissue engineering of heart valves: advances and current challenges. | Q37472099 | ||
| Translating autologous heart valve tissue engineering from bench to bed. | Q37486736 | ||
| Tissue-engineered heart valve scaffolds. | Q37676878 | ||
| Tissue-engineered heart valves. | Q37687339 | ||
| Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations. | Q37821592 | ||
| Heart valve tissue engineering: quo vadis? | Q37840436 | ||
| Mechanical factors in the degeneration of porcine bioprosthetic valves: an overview | Q38246997 | ||
| Tissue-engineered heart valve leaflets: does cell origin affect outcome? | Q38554892 | ||
| Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. | Q38560931 | ||
| Tissue engineering heart valves: valve leaflet replacement study in a lamb model | Q38564073 | ||
| Tissue-Engineered Grafts Matured in the Right Ventricular Outflow Tract. | Q38602335 | ||
| Assembly and Testing of Stem Cell-Seeded Layered Collagen Constructs for Heart Valve Tissue Engineering | Q39673523 | ||
| Vacuum-assisted cell seeding in a microwell cell culture system | Q39735836 | ||
| Heart valve tissue engineering | Q40381428 | ||
| Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. | Q40418262 | ||
| Tissue-engineered grafts matured in the right ventricular outflow tract. | Q40512206 | ||
| Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study | Q40593317 | ||
| Fibrin sealant: current and potential clinical applications | Q41348946 | ||
| Development of decellularized human umbilical arteries as small-diameter vascular grafts | Q42010408 | ||
| Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts | Q42470951 | ||
| Tissue-gel electrophoresis enhances antigen removal from porcine aortic valve and bovine pericardium | Q42760382 | ||
| Direct magnetic tubular cell seeding: a novel approach for vascular tissue engineering. | Q51103851 | ||
| The cardiovascular tissue-reactor: a novel device for the engineering of heart valves. | Q51122695 | ||
| Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. | Q51168487 | ||
| Autologous human tissue-engineered heart valves: prospects for systemic application. | Q51168548 | ||
| Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. | Q51188903 | ||
| Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. | Q51211040 | ||
| Tissue-engineered valves with commissural alignment. | Q51211044 | ||
| Successful endothelialization of porcine glutaraldehyde-fixed aortic valves in a heterotopic sheep model. | Q51241113 | ||
| Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. | Q51245248 | ||
| A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications. | Q51313795 | ||
| Porcine small intestine submucosa as a pulmonary valve leaflet substitute. | Q51370038 | ||
| Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. | Q51387259 | ||
| Performance of decellularized xenogeneic tissue in heart valve replacement. | Q51397552 | ||
| Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. | Q51542557 | ||
| Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. | Q51570240 | ||
| The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. | Q51659689 | ||
| Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. | Q51756063 | ||
| Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth | Q52102947 | ||
| Internal shear properties of fresh porcine aortic valve cusps: implications for normal valve function. | Q52309854 | ||
| Tears in bioprosthetic heart valve leaflets without calcific degeneration. | Q53994541 | ||
| New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. | Q54040776 | ||
| Executive Summary: Heart Disease and Stroke Statistics—2010 Update | Q57413935 | ||
| Extracellular matrix elasticity directs stem cell differentiation. | Q64915036 | ||
| Improved biocompatibility by postfixation treatment of aldehyde fixed bovine pericardium | Q68622654 | ||
| Vacuum cell seeding: a new method for the fast application of an evenly distributed cell layer on porous vascular grafts | Q68663165 | ||
| Analysis of the bending behaviour of porcine xenograft leaflets and of natural aortic valve material: bending stiffness, neutral axis and shear measurements | Q69243969 | ||
| Acidic glycosaminoglycans in human heart valves | Q71563685 | ||
| Glutaraldehyde fixation alters the internal shear properties of porcine aortic heart valve tissue | Q71986663 | ||
| Functional living trileaflet heart valves grown in vitro | Q73199670 | ||
| Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue | Q73199673 | ||
| Dynamic Rotational Seeding and Cell Culture System for Vascular Tube Formation | Q73376071 | ||
| Different modes of degeneration in autologous and heterologous heart valve prostheses | Q73456922 | ||
| Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients | Q73580561 | ||
| Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress | Q73663447 | ||
| Tissue-engineered heart valve on acellular aortic valve scaffold: in-vivo study | Q73702965 | ||
| Engineering of human vascular aortic tissue based on a xenogeneic starter matrix | Q74087493 | ||
| Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells | Q74464291 | ||
| The role of elastin in aortic valve mechanics | Q74566132 | ||
| Reduction of calcification by various treatments in cardiac valves | Q77957675 | ||
| Tissue engineering of functional trileaflet heart valves from human marrow stromal cells | Q78299134 | ||
| Isolation, propagation, and characterization of human umbilical cord perivascular cells (HUCPVCs) | Q83001064 | ||
| Decellularized heterografts versus cryopreserved homografts: experimental study in sheep model | Q84018037 | ||
| The Early and Midterm Function of Decellularized Aortic Valve Allografts | Q42795400 | ||
| Effective cell-seeding technique using magnetite nanoparticles and magnetic force onto decellularized blood vessels for vascular tissue engineering | Q42826863 | ||
| Role of fiber diameter in adhesion and proliferation of NIH 3T3 fibroblast on electrospun polycaprolactone scaffolds | Q42828107 | ||
| In-vivo assessment of a novel polymer (SIBS) trileaflet heart valve | Q42905886 | ||
| Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet | Q43058357 | ||
| Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering | Q43434955 | ||
| Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering | Q43577924 | ||
| Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent | Q43956093 | ||
| Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. | Q44022321 | ||
| Towards tissue engineering of a composite aortic valve | Q44042395 | ||
| Synthesis and characterization of photocrosslinkable, degradable poly(vinyl alcohol)-based tissue engineering scaffolds. | Q44057213 | ||
| Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold | Q44084149 | ||
| Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. | Q44084151 | ||
| Preseeding with autologous fibroblasts improves endothelialization of glutaraldehyde-fixed porcine aortic valves | Q44377108 | ||
| Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration | Q44407756 | ||
| Early in vivo experience with tissue-engineered trileaflet heart valves. | Q44497510 | ||
| Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves | Q44553958 | ||
| Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. | Q44755454 | ||
| The persistence of electrostatically seeded endothelial cells lining a small diameter expanded polytetrafluoroethylene vascular graft | Q44885611 | ||
| Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves | Q44905309 | ||
| Construction of autologous human heart valves based on an acellular allograft matrix. | Q44928133 | ||
| The effect of dynamic culture conditions on endothelial cell seeding and retention on small diameter polyurethane vascular grafts. | Q45253102 | ||
| Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model | Q46149001 | ||
| Fabrication of biomatrix/polymer hybrid scaffold for heart valve tissue engineering in vitro | Q46228652 | ||
| Plasmin degradation of fibrin coatings on synthetic polymer substrates | Q46332546 | ||
| Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. | Q46688959 | ||
| Interaction of human valve interstitial cells with collagen matrices manufactured using rapid prototyping | Q46889139 | ||
| Electrospun bioresorbable trileaflet heart valve prosthesis for tissue engineering: in vitro functional assessment of a pulmonary cardiac valve design | Q47428056 | ||
| Electrospun bioresorbable heart valve scaffold for tissue engineering | Q47902558 | ||
| Viewpoint: Heart valve engineering. Interview by James Butcher | Q48552213 | ||
| In vitro modelling of tissue using isolated vascular cells on a synthetic collagen matrix as a substitute for heart valves. | Q50504074 | ||
| Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. | Q50999167 | ||
| Biomechanical characterization of decellularized and cross-linked bovine pericardium. | Q51010577 | ||
| The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. | Q51015679 | ||
| Mechanics of oriented electrospun nanofibrous scaffolds for annulus fibrosus tissue engineering. | Q51018409 | ||
| Characterization of structural and signaling molecules by human valve interstitial cells and comparison to human mesenchymal stem cells. | Q51062819 | ||
| P433 | issue | 2 | |
| P921 | main subject | tissue engineering | Q1540285 |
| aorta | Q101004 | ||
| P304 | page(s) | 179-202 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Hindawi Journal of Engineering | Q15816371 |
| P1476 | title | Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering | |
| P478 | volume | 3 |
| Q58776175 | Biochemical and histological evidence of deteriorated bioprosthetic valve leaflets: the accumulation of fibrinogen and plasminogen |
| Q92401510 | Bioreactor Conditioning of Valve Scaffolds Seeded Internally with Adult Stem Cells |
| Q38364917 | Cells for tissue engineering of cardiac valves |
| Q47331717 | Detergent-based decellularization strategy preserves macro- and microstructure of heart valves |
| Q36330098 | Functional Heart Valve Scaffolds Obtained by Complete Decellularization of Porcine Aortic Roots in a Novel Differential Pressure Gradient Perfusion System |
| Q37178953 | Hyaluronan Hydrogels for a Biomimetic Spongiosa Layer of Tissue Engineered Heart Valve Scaffolds |
| Q92096226 | In Vivo Testing of Xenogeneic Acellular Aortic Valves Seeded with Stem Cells |
| Q89889298 | In vivo tissue engineering of a trilayered leaflet-shaped tissue construct |
| Q41817442 | Integrating valve-inspired design features into poly(ethylene glycol) hydrogel scaffolds for heart valve tissue engineering. |
| Q27308660 | Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs |
| Q92898919 | Structure and Rheological Properties of Bovine Aortic Heart Valve and Pericardium Tissue: Implications in Bioprosthetic and Tissue-Engineered Heart Valves |
| Q37174654 | Tissue engineering of heart valves: PEGylation of decellularized porcine aortic valve as a scaffold for in vitro recellularization |
Search more.